Kyle C. Strickland

ORCID: 0000-0003-1636-5277 · 2 papers in corpus
2017
Oncoimmunology ·doi:10.1080/2162402x.2016.1277308

Clear cell ovarian carcinoma (CCOC) represents a distinct histologic subtype of ovarian cancer associated with significantly worse prognosis across all stages and no effective therapeutic options. Here, we report a rare but clinically impor…

article 2016
·doi:10.1200/jco.2016.34.15_suppl.5514

5514 Background: Studies of immune checkpoint inhibitors (e.g., anti-PD-1/PD-L1 antibodies) in ovarian cancer have demonstrated isolated responses in tumors with clear cell histology. In order to assess the immunogenicity of clear cell ovar…